RT @WCMEnglanderIPM: ICYMI: @WCMEnglanderIPM Clinical Director Dr. Cora Sternberg (@cnsternberg) co-authored, "The Effect of Corticosteroid…
RT @WCMEnglanderIPM: ICYMI: @WCMEnglanderIPM Clinical Director Dr. Cora Sternberg (@cnsternberg) co-authored, "The Effect of Corticosteroid…
ICYMI: @WCMEnglanderIPM Clinical Director Dr. Cora Sternberg (@cnsternberg) co-authored, "The Effect of Corticosteroids on #prostatecancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial," in @CCR_AACR
RT @CCR_AACR: Phase 3 Study: AFFIRM Analysis of Enzalutamide and Corticosteroid Use. https://t.co/7IkoiRirCp https://t.co/N9Rcubpg0K
Phase 3 Study: AFFIRM Analysis of Enzalutamide and Corticosteroid Use. https://t.co/7IkoiRirCp https://t.co/N9Rcubpg0K
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
Really interesting data and yes, GR agonism is a concern but many respond to steroids, esp dex, so need answers as to why. Maybe due to underlying genetic variation in steroid metabolism @NimaSharifiMD
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
RT @OncHahn: Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to t…
Interesting study on the impact of steroid use on clinical outcomes with enzalutamide by @JZ_MDPhD @sloan_kettering. Adds to the lit on the complex role of steroids and GR in CRPC. And may be useful in the clinic when using AR antagonists. https://t.co/ij3
The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial https://t.co/pLP0UdDsCZ
RT @CCR_AACR: Metastatic castration-resistant #ProstateCancer patients benefited from #enzalutamide treatment independent of concurrent #co…
Metastatic castration-resistant #ProstateCancer patients benefited from #enzalutamide treatment independent of concurrent #corticosteroid use which was associated with worse baseline prognostic factors and outcomes. https://t.co/S785J1My8N @AarmstrongDuke
RT @PfizerOncMed: See an analysis of the phase 3 AFFIRM trial examining the association of concurrent corticosteroid use & prognostic facto…
RT @PfizerOncMed: See an analysis of the phase 3 AFFIRM trial examining the association of concurrent corticosteroid use & prognostic facto…
The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial https://t.co/tcoc9NSf3j
Thanks my mentor Howard Scher, co-authors and PCF YIA funding from @PCFnews @soulehoward1. Took a few years but finally my first clinical study is out! The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide. https://
New article: The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial https://t.co/ziOZalmgTt #prostatecancer #oncology https://t.co/QtndwVpL1t
The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial https://t.co/0xxmaeKaf3